Heart monitoring during virtual cardiac rehab
Part of Heart & circulation clinical trials.
This study tests a wearable heart monitor (CardioWatch) during your virtual cardiac rehab program. The monitor tracks your heart rhythm to help you and your care team better manage your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are enrolled in the HEARTS in Sync virtual cardiac rehab program in Nova Scotia.
- You have a compatible smartphone: Apple with iOS 14.5 or newer, or Android with version 8.0 or newer.
- Your phone supports Bluetooth 5.0 Low Energy.
- Your phone is not one of these models: Huawei P8 Lite, P9 Lite, P20 Lite, or Xiaomi Mi 6.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartwatch app that may help you avoid future heart problems. It is designed for people who are already going through cardiac rehabilitation, which is a program of exercise and education to help your heart get stronger.
This trial tests a smartwatch tool to track heart rhythm and detect problems in people with heart disease. It may help find irregular heartbeats early during routine checkups.
This study tests a smartphone app (HeartMate) that helps you manage heart health between doctor visits. It might help you track your heart disease risk factors and stay on top of your recovery.
This study tests if a smartwatch can help alert doctors to heart problems early in people who recently had a heart attack and have high blood pressure. It aims to improve recovery and prevent future heart issues.
This study looks at how well a wearable heart monitor and special software can check the health of your whole heart and assess your risk of future heart problems. It may help doctors create more personalized care plans.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
Hear when a new ASCVD Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.